Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropinirole CR in Restless Legs Syndrome
NCT00530790Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ropinirole in restless legs syndrome (RLS), sponsored by GSK. Primary endpoints: Drug Related Adverse Events-On-Therapy, Haematology Clinical Lab Values Change From Baseline at Week 13 and 4 more. Started Aug 2007; status: completed.
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT00530790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530790.